Vivani Plans Cortigent-ClearOne Merger to Create Nasdaq-Listed Cortigent Holdings
Vivani is merging subsidiary Cortigent with ClearOne, rebranding the Nasdaq firm as Cortigent Holdings under ticker 'CRGT'.
Vivani is making a bold move in the medtech space, announcing plans to merge its wholly owned subsidiary Cortigent, Inc. with a subsidiary of Nasdaq-listed ClearOne, Inc. (CLRO). The deal would fundamentally transform ClearOne, stripping it of its current identity and replacing it with a new corporate brand built around Cortigent's technology.
Under the terms of the proposed merger, the surviving listed entity would be renamed Cortigent Holdings, Inc. — operating under the trade name Cortigent — and would trade on Nasdaq under the fresh ticker symbol "CRGT." That's a full rebrand, not just a name tweak. If you're holding CLRO shares, pay attention.
Read more Dollar Drops After Jobs Miss, But Bounce Fades Fast →
For traders, this is a classic reverse-merger setup where a private operating company gains a public market listing by folding into an existing Nasdaq shell. Vivani essentially gets Cortigent onto the public markets without a traditional IPO, and ClearOne shareholders wake up owning a piece of a completely different business. That kind of transformation can swing a stock hard in either direction once the market digests what Cortigent actually does.
The announcement signals Vivani's ambition to spin out Cortigent into its own publicly traded vehicle, giving the neurotechnology unit direct access to capital markets. Watch the CLRO chart closely — deal uncertainty and speculative positioning around merger announcements like this tend to create volatile, tradeable windows before a shareholder vote closes the book.
Continue reading at GlobalNewswire.
